EnzyTag

Description

EnzyTag develops peptiligase-based synthetic routes for manufacturing peptide new chemical entities, small proteins, and peptide bioconjugates, applying the technology to linear and cyclic peptide drugs, antibody drug conjugates, PROTACs, and LYTACs.

EnzyTag is located in the Netherlands ecosystem.

Related

• VRG TherapeuticsVRG Therapeutics designs therapeutic miniproteins using a proprietary platform that combines AI-driven protein engineering with wet-lab…
• OncopeptidesOncopeptides develops peptide drug conjugates that use tumor-overexpressed peptidases and esterases to release an alkylating payload…
• Cristal TherapeuticsCristal Therapeutics offers CliCr®, a copper-free click chemistry reagent for life science users that supports faster reactions and…
• ZoBioZoBio helps biopharma companies identify small molecules for drug targets, applying protein-science expertise, biophysical and biochemical…
• OrexoOrexo develops powder-based drug delivery technologies and therapeutic formulations, including AmorphOX®, used to improve bioavailability…
• Rab DiagnosticsRab Diagnostics develops biomarker tools, assays and the RabCANCER platform to predict antibody–drug conjugate response for pharma…
• 21st.BIO21st.BIO A/S provides precision fermentation technology for proteins and peptides, using microbial strains, fermentation processes, and…
• BBelynticBelyntic develops T-Fender vaccines that use self-adjuvant, self-aggregating synthetic long peptides, combined with AI-based prediction, to…
• TubulisTubulis generates antibody–drug conjugates and administers them with a proprietary platform that yields uniquely matched ADCs having…